|
 |
Prostate Cancer > Agonist
The following information is about Agonist.
Agonist Defined
A drug or other chemical that can combine with a receptor on a cell to produce a physiologic reaction typical of a naturally occurring substance
This definition is in context to Prostate Cancer. See more contextual defintions for Agonist.
Early Breast Cancer: LHRH Agonists Show Considerable Promise
Published October 10, 2008, 9:10 am, Science Daily
Women who have had early stage breast cancer surgically removed, and whose tumor cells are stimulated by the hormone estrogen, can benefit from taking luteinizing hormone releasing hormone antagonists, a Cochrane systematic review has concluded. This medication may be taken alone or alongside the use of tamoxifen.
Nventa Provides Corporate Update and Advancement Plans for HspE7, Hsp 6/11 and Poly-ICR
Published October 9, 2008, 8:50 am, T-Net British Columbia
Vancouver, BC, October 9, 2008--(T-Net)--Nventa Biopharmaceuticals (TSX: NVN), a company developing innovative therapeutics for the treatment of viral infections and cancer, today provided an update on its ongoing development programs.
Nventa Presents Findings On Proprietary Toll-like Receptor 3 (TLR3) Agonist, Poly-ICR, At World Vaccine Congres
Published October 9, 2008, 4:06 am, Medical News Today
Nventa Biopharmaceuticals Corporation (TSX: NVN) presented positive data from preclinical studies using its proprietary Toll-like Receptor 3 agonist, Poly IC-Poly Arginine (Poly-ICR), at the World Vaccine Congress 2008 in Lyon, France. Study results demonstrated Poly-ICR to be a potent vaccine adjuvant targeting the Toll-like Receptor 3 (TLR3) pathway.
LHRH Agonists Show Considerable Promise In Early Breast Cancer
Published October 8, 2008, 12:09 pm, Medical News Today
Women who have had early stage breast cancer surgically removed, and whose tumour cells are stimulated by the hormone oestrogen, can benefit from taking Luteinizing hormone releasing hormone (LHRH) antagonists, a Cochrane Systematic Review has concluded. This medication may be taken alone or alongside the use of tamoxifen.
Cenomed and TorreyPines Therapeutics Enter into Licensing Agreement
Published October 8, 2008, 5:05 am, Business Wire via Yahoo! Finance
IRVINE, Calif. & LA JOLLA, Calif.----Cenomed BioSciences, LLC, a majority-owned subsidiary of Abraxis BioScience, Inc. , and TorreyPines Therapeutics, Inc. today announced that they have entered into an exclusive licensing agreement whereby Cenomed acquired from TorreyPines Therapeutics the worldwide development rights held by TorreyPines to three compounds: phenserine, Posiphen™ and ...
Nventa Presents Findings on Proprietary Toll-like Receptor 3 (TLR3) Agonist, Poly-ICR, at World Vaccine Congress
Published October 8, 2008, 4:30 am, PR Newswire via Yahoo! Finance
Nventa Biopharmaceuticals Corporation today presented positive data from preclinical studies using its proprietary Toll-like Receptor 3 agonist, Poly IC-Poly Arginine , at the World Vaccine Congress 2008 in Lyon, France.
AEterna enters second stage of patient recruitment for Phase II cancer trial
Published October 3, 2008, 5:36 pm, Pharmaceutical Business Review
AEterna Zentaris, a biopharmaceutical company, has entered the second stage of patient recruitment for its Phase II trial in ovarian cancer with AEZS-108, a luteinizing hormone-releasing hormone agonist linked to doxorubicin.
Are you looking for additional Prostate Cancer > Agonist news? Try our new "Agonist News Focus" area.
Off-site Agonist Links, User Submitted
The following links have been collected through user bookmark submission in the Agonist category. Please note, because these resources are off-site we cannot guarantee the accuracy or quality of any information.
Wed Sep 24
Sat Sep 20
Tue Aug 12
Mon Aug 11
- The Next Step in Moderate Asthma: Patients in the moderate group who are still symptomatic with reduced activity and flow rates despite the combination of a long-acting B2-adrenergic agonist and medium doses of an inhaled...
Fri Aug 1
- Cardiovascular safety determines the direction of PPAR agonist R&D: The field of novel PPAR delta and of triple (or pan-) PPAR agonists is lead by GSK.
- PPAR agonists in the treatment of atherosclerosi s: Only PPAR-d agonists have been shown clinically to improve the outcome of atheroscleroti c heart disease; however, it will only be a matter of time before we know whether compounds that modulate the function of ppar-y are also efficacious at combating atherosclerosi s.
Sun Feb 24
Tue Feb 12
Wed Jan 30
Fri Dec 14
- varenicline - [Medication]: Varenicline is a smoking cessation medicine. It is used together with behavior modification and counseling support to help you stop smoking.
If you would like to find additional social bookmark based links on the topic of we recommend the Open Tag Directory > Agonist. If you would like to find related tags we recommend Tag Patterns > Agonist
Off-site Agonist Research Links
If you still need additional information on Agonist then we suggest the following off-site resources. Please note, because these resources are off-site we cannot guarantee the accuracy or quality of any information.
Prostate Cancer Topics
Everything you need to know about Prostate Cancer
Prostate Cancer
If you know the Prostate Cancer Term Name use the links below to quickly jump to your desired focus.
Bookmark Us
The On Topic Network
This website is part of The On Topic Network.
Thank You
Prostate-Cancer.On-Topic.net was developed by Odin Metatech, Inc and runs on the Odin Assemble platform.
Best Viewed With
License
This work is licensed under Creative Commons.